Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations across Europe, Russia and other C.I.S. countries, Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia. An efficient and reliable production system and a global sales and marketing organization promote a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories.
Serves as the central hub for global operations, strategic decision-making, research and development oversight, corporate governance, and international market coordination for the pharmaceutical group.
Modern office facilities designed to foster collaboration and innovation. While specific architectural details are not widely publicized, it is expected to be a contemporary corporate building suited for a global pharmaceutical leader.
The headquarters likely fosters a work culture emphasizing scientific excellence, ethical practices, innovation, and a commitment to patient well-being. A collaborative, results-oriented, and international environment is characteristic of its operations.
The Milan headquarters is crucial as it anchors Recordati's global strategy and operations, leveraging Italy's strong pharmaceutical heritage and its strategic position within the European market.
Recordati supports a wide range of functions globally, including research and development, manufacturing through its own plants and contract manufacturers, marketing, sales, and distribution of pharmaceutical products. The company has a direct commercial presence in key Western European countries (like Italy, France, Germany, Spain, UK), Central and Eastern Europe (including Poland, Czech Republic, Romania), Russia, Turkey, North Africa, the USA, Canada, Mexico, select South American countries (e.g., Brazil, Colombia), Japan, and Australia. Its global operations are structured to effectively manage its Specialty and Primary Care portfolio and its dedicated Rare Diseases business, ensuring focused support for diverse therapeutic areas and patient populations worldwide.
Via Matteo Civitali, 1
Milan
MI
Italy
Address: 500 US-202, Bridgewater, NJ 08807, USA
To serve patients with rare diseases in North America, manage clinical trials, navigate regulatory affairs, and lead commercial operations for Recordati's specialized rare disease portfolio in the region.
Address: C/Isabel Colbrand 22, Edificio Alfa III – Planta 3ª, 28050 Madrid, Spain
To strengthen Recordati's market presence in Spain and Portugal (Iberian region), address local healthcare needs, and manage sales, marketing, and medical affairs operations.
Address: Immeuble "Le Wilson", 70 avenue du Général de Gaulle, 92800 Puteaux, France
To drive growth and market penetration in France, ensure regulatory compliance, and tailor marketing strategies for Recordati's products to French healthcare professionals and patients.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Recordati' leadership includes:
Recordati has been backed by several prominent investors over the years, including:
Recordati has experienced significant leadership transitions in the past 12 months (approx. May 2023 - May 2024), including the appointment of a new CEO and Chairman, reflecting strategic moves to guide the company's future growth. Key changes also included a new Head of Investor Relations & Corporate Communications and the departure of the Chief Technical Officer.
Discover the tools Recordati uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Recordati's common email formats typically involve combinations of first name and last name. The most frequently observed pattern is [first_initial].[last]@recordati.com. Other formats like [first].[last]@recordati.com might also be in use within the organization.
[first_initial].[last]@recordati.com
Format
j.doe@recordati.com
Example
85%
Success rate
Recordati Official Website • May 8, 2024
Recordati reported strong Q1 2024 financial results with consolidated revenue at €607.5 million, up by 10.1% (9.0% at constant exchange rates), and EBITDA at €226.0 million, up by 11.3% compared to Q1 2023. Net income for the quarter was €135.1 million, an increase of 12.2%....more
Recordati Official Website • April 3, 2024
Recordati announced the appointment of Federica D’Alia as the new Head of Investor Relations & Corporate Communications, effective from April 2, 2024. She brings extensive experience in finance and communication and will report directly to the Group CFO, Luigi La Corte....more
Recordati Official Website • January 30, 2024
Recordati announced its preliminary consolidated results for 2023, with revenue exceeding €2 billion (€2,086.5 million), a 12.1% increase over 2022. EBITDA reached €760.5 million, and net income was €420.8 million. The company also proposed a dividend distribution....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Recordati, are just a search away.